LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: Pathological Assessment of Chronic Traumatic Encephalopathy: Review of Concepts and Methodology.

    Van Ommeren, Randy / Hazrati, Lili-Naz

    Academic forensic pathology

    2018  Volume 8, Issue 3, Page(s) 555–564

    Abstract: Chronic traumatic encephalopathy (CTE) has become a topic of considerable interest in recent years, with wide-ranging implications for athletes, military members, and other groups exposed to frequent concussive or subconcussive head trauma. The condition ...

    Abstract Chronic traumatic encephalopathy (CTE) has become a topic of considerable interest in recent years, with wide-ranging implications for athletes, military members, and other groups exposed to frequent concussive or subconcussive head trauma. The condition has been subject to intensive neuropathological characterization by various groups, with assessment methodologies and staging criteria proposed. Clinical characterization of symptoms has also been performed, but has not yet been definitively formalized. While efforts are underway to develop
    Language English
    Publishing date 2018-08-31
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 1925-3621
    ISSN (online) 1925-3621
    DOI 10.1177/1925362118797729
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical Reasoning: An 81-year-old woman with decreased consciousness and fluctuating right facial droop.

    Van Ommeren, Randy / Izenberg, Aaron / Shadowitz, Steven / Aviv, Richard / Keith, Julia

    Neurology

    2020  Volume 94, Issue 19, Page(s) 843–848

    MeSH term(s) Aged, 80 and over ; Cerebral Amyloid Angiopathy/cerebrospinal fluid ; Cerebral Amyloid Angiopathy/complications ; Cerebral Amyloid Angiopathy/diagnosis ; Cerebral Amyloid Angiopathy/pathology ; Cerebrospinal Fluid Proteins/metabolism ; Diagnosis, Differential ; Facial Paralysis/complications ; Female ; Humans ; Magnetic Resonance Imaging ; Subarachnoid Hemorrhage/complications ; Tomography, X-Ray Computed ; Unconsciousness/complications ; Unconsciousness/diagnosis ; Vasculitis, Central Nervous System/cerebrospinal fluid ; Vasculitis, Central Nervous System/complications ; Vasculitis, Central Nervous System/diagnosis ; Vasculitis, Central Nervous System/pathology ; White Matter/pathology
    Chemical Substances Cerebrospinal Fluid Proteins
    Language English
    Publishing date 2020-04-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 207147-2
    ISSN 1526-632X ; 0028-3878
    ISSN (online) 1526-632X
    ISSN 0028-3878
    DOI 10.1212/WNL.0000000000009410
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Diffuse intrinsic pontine glioma: current insights and future directions.

    Srikanthan, Dilakshan / Taccone, Michael S / Van Ommeren, Randy / Ishida, Joji / Krumholtz, Stacey L / Rutka, James T

    Chinese neurosurgical journal

    2021  Volume 7, Issue 1, Page(s) 6

    Abstract: Diffuse intrinsic pontine glioma (DIPG) is a lethal pediatric brain tumor and the leading cause of brain tumor-related death in children. As several clinical trials over the past few decades have led to no significant improvements in outcome, the current ...

    Abstract Diffuse intrinsic pontine glioma (DIPG) is a lethal pediatric brain tumor and the leading cause of brain tumor-related death in children. As several clinical trials over the past few decades have led to no significant improvements in outcome, the current standard of care remains fractionated focal radiation. Due to the recent increase in stereotactic biopsies, tumor tissue availabilities have enabled our advancement of the genomic and molecular characterization of this lethal cancer. Several groups have identified key histone gene mutations, genetic drivers, and methylation changes in DIPG, providing us with new insights into DIPG tumorigenesis. Subsequently, there has been increased development of in vitro and in vivo models of DIPG which have the capacity to unveil novel therapies and strategies for drug delivery. This review outlines the clinical characteristics, genetic landscape, models, and current treatments and hopes to shed light on novel therapeutic avenues and challenges that remain.
    Language English
    Publishing date 2021-01-11
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2836334-6
    ISSN 2057-4967 ; 2057-4967
    ISSN (online) 2057-4967
    ISSN 2057-4967
    DOI 10.1186/s41016-020-00218-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The molecular biology of medulloblastoma metastasis.

    Van Ommeren, Randy / Garzia, Livia / Holgado, Borja L / Ramaswamy, Vijay / Taylor, Michael D

    Brain pathology (Zurich, Switzerland)

    2020  Volume 30, Issue 3, Page(s) 691–702

    Abstract: Medulloblastoma (MB) is the most common primary malignant brain tumor of childhood and a significant contributor to pediatric morbidity and death. While metastatic dissemination is the predominant cause of morbidity and mortality for patients with this ... ...

    Abstract Medulloblastoma (MB) is the most common primary malignant brain tumor of childhood and a significant contributor to pediatric morbidity and death. While metastatic dissemination is the predominant cause of morbidity and mortality for patients with this disease, most research efforts and clinical trials to date have focused on the primary tumor; this is due mostly to the paucity of metastatic tumor samples and lack of robust mouse models of MB dissemination. Most current insights into the molecular drivers of metastasis have been derived from comparative molecular studies of metastatic and non-metastatic primary tumors. However, small studies on matched primary and metastatic tissues and recently developed mouse models of dissemination have begun to uncover the molecular biology of MB metastasis more directly. With respect to anatomical routes of dissemination, a hematogenous route for MB metastasis has recently been demonstrated, opening new avenues of investigation. The tumor micro-environment of the primary and metastatic niches has also been increasingly scrutinized in recent years, and further investigation of these tumor compartments is likely to result in a better understanding of the molecular mediators of MB colonization and growth in metastatic compartments.
    MeSH term(s) Cell Line, Tumor ; Cerebellar Neoplasms/genetics ; Cerebellar Neoplasms/pathology ; Humans ; Medulloblastoma/genetics ; Medulloblastoma/secondary ; Neoplasm Metastasis/genetics ; Neoplasm Metastasis/pathology ; Tumor Microenvironment/genetics
    Language English
    Publishing date 2020-01-15
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 1051484-3
    ISSN 1750-3639 ; 1015-6305
    ISSN (online) 1750-3639
    ISSN 1015-6305
    DOI 10.1111/bpa.12811
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Deep learning for image analysis: Personalizing medicine closer to the point of care.

    Xie, Quin / Faust, Kevin / Van Ommeren, Randy / Sheikh, Adeel / Djuric, Ugljesa / Diamandis, Phedias

    Critical reviews in clinical laboratory sciences

    2019  Volume 56, Issue 1, Page(s) 61–73

    Abstract: The precision-based revolution in medicine continues to demand stratification of patients into smaller and more personalized subgroups. While genomic technologies have largely led this movement, diagnostic results can take days to weeks to generate. ... ...

    Abstract The precision-based revolution in medicine continues to demand stratification of patients into smaller and more personalized subgroups. While genomic technologies have largely led this movement, diagnostic results can take days to weeks to generate. Management at, or closer to, the point of care still heavily relies on the subjective qualitative interpretation of clinical and diagnostic imaging findings. New and emerging technological advances in artificial intelligence (AI) now appear poised to help bring objectivity and precision to these traditionally qualitative analytic tools. In particular, one specific form of AI, known as deep learning, is achieving expert-level disease classifications in many areas of diagnostic medicine dependent on visual and image-based findings. Here, we briefly review concepts of deep learning, and more specifically recent developments in convolutional neural networks (CNNs), to highlight their transformative potential in personalized medicine and, in particular, diagnostic histopathology. Understanding the opportunities and challenges of these quantitative machine-based decision support tools is critical to their widespread introduction into routine diagnostics.
    MeSH term(s) Deep Learning ; Diagnosis, Computer-Assisted ; Humans ; Neural Networks (Computer) ; Pattern Recognition, Automated ; Point-of-Care Systems ; Precision Medicine
    Language English
    Publishing date 2019-01-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 280641-1
    ISSN 1549-781X ; 1040-8363 ; 0590-8191
    ISSN (online) 1549-781X
    ISSN 1040-8363 ; 0590-8191
    DOI 10.1080/10408363.2018.1536111
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: BRAT1 Mutation: The First Reported Case of Chinese Origin and Review of the Literature.

    Van Ommeren, Randy H / Gao, Andrew F / Blaser, Susan I / Chitayat, David A / Hazrati, Lili-Naz

    Journal of neuropathology and experimental neurology

    2018  Volume 77, Issue 12, Page(s) 1071–1078

    Abstract: Lethal neonatal rigidity and multifocal seizure syndrome (RMFSL) (OMIM#614498) is caused by homozygous or compound heterozygous mutation in the BRAT1 gene (OMIM#614506) on chromosome 7p22. We report a newborn female infant born to non-consanguineous ... ...

    Abstract Lethal neonatal rigidity and multifocal seizure syndrome (RMFSL) (OMIM#614498) is caused by homozygous or compound heterozygous mutation in the BRAT1 gene (OMIM#614506) on chromosome 7p22. We report a newborn female infant born to non-consanguineous Chinese parents who presented with hypertonia, dysmorphic features, progressive encephalopathy with refractory seizures, and worsening episodic apnea, leading to intubation and eventually death at 10 weeks of age. Whole exome sequencing revealed homozygous BRAT1 mutation, c.1395G>C (p.Thr465Thr), predicted to cause splice site disruption. Neuropathological assessment demonstrated microcephaly, severe neuronal loss, and background gliosis in the dorsal region of the putamen. Disruption of BRAT1 function in RMFSL has been proposed to cause dysfunction in the DNA damage response pathway and impair mitochondrial homeostasis. To our best knowledge this is the first reported case of Chinese origin. We review all published cases with BRAT1 mutation reported in the English literature and known BRAT1 functions which provide insight into the pathophysiology of the disease.
    MeSH term(s) Asian Continental Ancestry Group/genetics ; Brain/abnormalities ; Brain/diagnostic imaging ; Fatal Outcome ; Female ; Humans ; Infant ; Infant, Newborn ; Mutation/genetics ; Nuclear Proteins/genetics ; Seizures/diagnostic imaging ; Seizures/genetics
    Chemical Substances BRAT1 protein, human ; Nuclear Proteins
    Language English
    Publishing date 2018-10-22
    Publishing country England
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 3088-0
    ISSN 1554-6578 ; 0022-3069
    ISSN (online) 1554-6578
    ISSN 0022-3069
    DOI 10.1093/jnen/nly093
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Advances in HSP27 and HSP90-targeting strategies for glioblastoma.

    van Ommeren, Randy / Staudt, Michael D / Xu, Hu / Hebb, Matthew O

    Journal of neuro-oncology

    2016  Volume 127, Issue 2, Page(s) 209–219

    Abstract: Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. There is a critical need for novel strategies to abolish the molecular mechanisms that support GBM growth, invasion and treatment resistance. The heat shock proteins, ... ...

    Abstract Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. There is a critical need for novel strategies to abolish the molecular mechanisms that support GBM growth, invasion and treatment resistance. The heat shock proteins, HSP27 and HSP90, serve these pivotal roles in tumor cells and have been identified as effective targets for developing therapeutics. Natural and synthetic inhibitors have been evaluated in clinical trials for several forms of systemic cancer but none as yet for GBM. This topic review summarizes the current preclinical evidence and rationale to define the potential of HSP27 and HSP90 inhibitors in GBM management.
    MeSH term(s) Adult ; Antineoplastic Agents/therapeutic use ; Glioblastoma/drug therapy ; Glioblastoma/metabolism ; HSP27 Heat-Shock Proteins/antagonists & inhibitors ; HSP90 Heat-Shock Proteins/antagonists & inhibitors ; Humans ; Molecular Targeted Therapy
    Chemical Substances Antineoplastic Agents ; HSP27 Heat-Shock Proteins ; HSP90 Heat-Shock Proteins
    Language English
    Publishing date 2016-04
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 604875-4
    ISSN 1573-7373 ; 0167-594X
    ISSN (online) 1573-7373
    ISSN 0167-594X
    DOI 10.1007/s11060-016-2070-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Physician perspectives on integration of artificial intelligence into diagnostic pathology.

    Sarwar, Shihab / Dent, Anglin / Faust, Kevin / Richer, Maxime / Djuric, Ugljesa / Van Ommeren, Randy / Diamandis, Phedias

    NPJ digital medicine

    2019  Volume 2, Page(s) 28

    Abstract: Advancements in computer vision and artificial intelligence (AI) carry the potential to make significant contributions to health care, particularly in diagnostic specialties such as radiology and pathology. The impact of these technologies on physician ... ...

    Abstract Advancements in computer vision and artificial intelligence (AI) carry the potential to make significant contributions to health care, particularly in diagnostic specialties such as radiology and pathology. The impact of these technologies on physician stakeholders is the subject of significant speculation. There is however a dearth of information regarding the opinions, enthusiasm, and concerns of the pathology community at large. Here, we report results from a survey of 487 pathologist-respondents practicing in 54 countries, conducted to examine perspectives on AI implementation in clinical practice. Despite limitations, including difficulty with quantifying response bias and verifying identity of respondents to this anonymous and voluntary survey, several interesting findings were uncovered. Overall, respondents carried generally positive attitudes towards AI, with nearly 75% reporting interest or excitement in AI as a diagnostic tool to facilitate improvements in workflow efficiency and quality assurance in pathology. Importantly, even within the more optimistic cohort, a significant number of respondents endorsed concerns about AI, including the potential for job displacement and replacement. Overall, around 80% of respondents predicted the introduction of AI technology in the pathology laboratory within the coming decade. Attempts to identify statistically significant demographic characteristics (e.g., age, sex, type/place of practice) predictive of attitudes towards AI using Kolmogorov-Smirnov (KS) testing revealed several associations. Important themes which were commented on by respondents included the need for increasing efforts towards physician training and resolving medical-legal implications prior to the generalized implementation of AI in pathology.
    Language English
    Publishing date 2019-04-26
    Publishing country England
    Document type Journal Article
    ISSN 2398-6352
    ISSN (online) 2398-6352
    DOI 10.1038/s41746-019-0106-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Conference proceedings: Surgical Management of Skull Base Chordomas: Single-Center Results in the Last 10 Years

    Almeida, Joao Paulo / Van Ommeren, Randy / Zuccato, Jeffrey / Vescan, Allan / de Almeida, John / Monteiro, Eric / Witterick, Ian / Gentili, Fred / Zadeh, Gelareh

    Journal of Neurological Surgery Part B: Skull Base

    2020  Volume 81, Issue S 01

    Event/congress 30th Annual Meeting North American Skull Base Society, La Cantera Resort & Spa San Antonio, Texas, 2020-02-07
    Language English
    Publishing date 2020-02-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article ; Conference proceedings
    ZDB-ID 2654269-9
    ISSN 2193-634X ; 2193-6331
    ISSN (online) 2193-634X
    ISSN 2193-6331
    DOI 10.1055/s-0040-1702488
    Database Thieme publisher's database

    More links

    Kategorien

  10. Article ; Online: Physician perspectives on integration of artificial intelligence into diagnostic pathology

    Shihab Sarwar / Anglin Dent / Kevin Faust / Maxime Richer / Ugljesa Djuric / Randy Van Ommeren / Phedias Diamandis

    npj Digital Medicine, Vol 2, Iss 1, Pp 1-

    2019  Volume 7

    Abstract: Abstract Advancements in computer vision and artificial intelligence (AI) carry the potential to make significant contributions to health care, particularly in diagnostic specialties such as radiology and pathology. The impact of these technologies on ... ...

    Abstract Abstract Advancements in computer vision and artificial intelligence (AI) carry the potential to make significant contributions to health care, particularly in diagnostic specialties such as radiology and pathology. The impact of these technologies on physician stakeholders is the subject of significant speculation. There is however a dearth of information regarding the opinions, enthusiasm, and concerns of the pathology community at large. Here, we report results from a survey of 487 pathologist-respondents practicing in 54 countries, conducted to examine perspectives on AI implementation in clinical practice. Despite limitations, including difficulty with quantifying response bias and verifying identity of respondents to this anonymous and voluntary survey, several interesting findings were uncovered. Overall, respondents carried generally positive attitudes towards AI, with nearly 75% reporting interest or excitement in AI as a diagnostic tool to facilitate improvements in workflow efficiency and quality assurance in pathology. Importantly, even within the more optimistic cohort, a significant number of respondents endorsed concerns about AI, including the potential for job displacement and replacement. Overall, around 80% of respondents predicted the introduction of AI technology in the pathology laboratory within the coming decade. Attempts to identify statistically significant demographic characteristics (e.g., age, sex, type/place of practice) predictive of attitudes towards AI using Kolmogorov–Smirnov (KS) testing revealed several associations. Important themes which were commented on by respondents included the need for increasing efforts towards physician training and resolving medical-legal implications prior to the generalized implementation of AI in pathology.
    Keywords Computer applications to medicine. Medical informatics ; R858-859.7
    Subject code 941
    Language English
    Publishing date 2019-04-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top